Location History:
- Gaithersburg, MD (US) (2016 - 2017)
- New York, NY (US) (2019 - 2020)
- Exton, PA (US) (2020 - 2021)
Company Filing History:
8 out of 541 
Years Active: 2016-2025
Title: Mladen Tomich: Innovator in Combination Therapies
Introduction
Mladen Tomich is a notable inventor based in Exton, PA (US), recognized for his contributions to the field of combination therapies. With a total of 7 patents, he has made significant strides in developing innovative solutions for medical treatments.
Latest Patents
Among his latest patents is a groundbreaking disclosure on combination therapies using anti-pseudomonas PSL and PCRV binding molecules. This invention relates to therapies that utilize anti-Psl and PcrV binding molecules, aimed at preventing and treating infections. Another significant patent involves polynucleotides encoding antibodies or antigen binding fragments that bind to PcrV, along with vectors and host cells that incorporate these polynucleotides.
Career Highlights
Mladen Tomich is currently associated with MedImmune Limited, where he continues to advance his research and development efforts. His work focuses on innovative therapeutic approaches that address critical health challenges.
Collaborations
Mladen collaborates with esteemed colleagues, including Antonio Digiandomenico and Paul Warrener, who contribute to his research endeavors.
Conclusion
Mladen Tomich's innovative work in combination therapies showcases his commitment to improving medical treatments through his patented inventions. His contributions are vital in the ongoing fight against infections and highlight the importance of collaboration in scientific research.